Has Sibel Deviren, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,798 in general payments to Sibel Deviren, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sibel Deviren, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sibel Deviren, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sibel Deviren, MD

Orthopaedic Surgery · San Francisco, CANPI 1760435655

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $17,993 of the $18,798 with a category attached, or 95.7%. Alphatec Spine, Inc accounts for 98.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $18,390 and has fallen 99.7% since, to $57 in 2025.

$18,798in general payments, 2019–2025

Across 6 payments — averaging $3133.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alphatec Spine, Inc$19K
MML US, Inc.$258

$146,968in research payments, 2019–2025

Across 7 payments — averaging $20,995 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$147K

What the payments were for

Royalty or licence$17,99396%
Food & beverage$8054%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alphatec Spine, Inc	4	$18,540
MML US, Inc.	2	$258

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,798 in reported general payments places this provider in the 75th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$100,788

Medicare patients

283

Services billed

895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Duloxetine Hcl	166	$8,140
Gabapentin	229	$6,996
Lidocaine	33	$3,072
Diclofenac Sodium	65	$2,643
Celecoxib	16	$847
Baclofen	42	$713
Bupropion XlBupropion Hcl	27	$591
Tizanidine Hcl	12	$309
Meloxicam	27	$247
Nortriptyline Hcl	15	$192
Cyclobenzaprine Hcl	12	$106

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Francisco

Tom NorrisSan Francisco$5.3M
Sigurd BervenSan Francisco$4.1M
Vedat DevirenSan Francisco$2.9M
Eugene WolfSan Francisco$988K
James KellySan Francisco$826K
Alexander TheologisSan Francisco$719K
Utku KandemirSan Francisco$484K
Bradford HackArcadia$18.3M
Robert GorabOrange$13.6M
Kelly VinceLos Angeles$9.6M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →